The Continuum of Biologic Treatment for Psoriasis: Looking Ahead with Pharmacists

Learn about the various biological treatments for psoriasis available in Canada and how to counsel patients on the administration of the biologic therapy risankizumab.

$0.00

Description

Description:

Psoriasis is a complex multifactorial inflammatory disease and biologics are an important treatment option for people with moderate-to-severe psoriasis. This program will outline the major comorbidities associated with psoriasis and how they impact a patient’s quality of life.

Learn about the various biological treatments for psoriasis available in Canada and how to counsel patients on the administration of the biologic therapy risankizumab.

You will also learn about potential side effects and expected efficacy of risankizumab and how to answer patient questions.

Learning objectives:

  • Describe the major comorbidities associated with psoriasis
    and how they impact patient quality of life
  • Contrast the mechanisms of action of the various biological treatments for psoriasis available in Canada in 2019
  • Counsel patients on the administration of the newly available biologic therapy
  • Apply knowledge of potential side effects and expected efficacy to answer questions from patients with psoriasis

Sponsor(s)

Course at a glance:

  • 1 hour to complete
  • Available until February 6, 2024
  • Online
  • Completion requirement: Complete the course’s online modules and complete the program evaluation.

Who should take this course:

This online professional development program is developed for pharmacists who would like to increase their knowledge..

Development Team:

  • Aaron Sihota BSc, BSc Pharm, RPh, Clinical Instructor UBC Faculty of Pharmaceutical Science
  • Rejean Lemay C.P.H., MBA, Lecturer University of Montreal Faculty of Pharmacy
  • Yves Poulin MD, FRCPC, Dermatologist
  • Carolyn Whiskin RPh, BScPhm, NCMP Pharmacist and Certified Menopause Practitioner
  • Michael Boivin, BSc. Pharm